...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ,Hong Kong exchange

***The only way they can raise capital is by an IPO. Otherwise stay private. ***

Not sure the above is correct,,,,,,,,,,,,,,,,,,an IPO is based on the tongue in cheek fundamentals that the market will place on the company,,,you dont get the irrational excuberance when private albeit the shares are given value based on the corporations assets......and we know that the market in general overvalues most companies by basing the theoretical net worth of what they think a few years out!!...so any hicupps in the business modle and the stock price pulls back pronto!!,,,nothing like buying stock that is priced on hopes and dreams by the market and the shareholder!!,,uggghhhh,,,, :o) ,,,jmo

Share
New Message
Please login to post a reply